Actuate Therapeutics , Inc., a biopharmaceutical company with a market capitalization of $172 million, announced today that it will hold its first Annual Meeting of Stockholders virtually on May 22, ...
Under the theme “Catalyzing Progress for a Resilient and Sustainable Future towards ARISE 2030,” the meeting was grounded in the words “Innovate, Integrate, and Elevate,” urging members to embrace new ...